FTC-FDA warning letters target treatment claims for Alzheimer’s, dementia, and other serious diseases
Alzheimer’s disease poses what experts agree is a looming public health crisis. But it also exacts an incalculable personal toll on people living with the condition and the family and friends who love them. The FTC and the Food and Drug Administration just sent warning letters to three companies advertising that their products can treat diseases like Alzheimer’s. It’s a development that merits industry attention. Like many consumers, the FTC and...